scholarly article | Q13442814 |
P50 | author | Michael Walter | Q39897202 |
P2093 | author name string | Michael Bonin | |
Thomas Iftner | |||
Frank Stubenrauch | |||
Sven Poppelreuther | |||
Bernd Karstensen | |||
P2860 | cites work | Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus | Q24292060 |
The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase | Q24521626 | ||
Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity | Q24599944 | ||
E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints | Q24672780 | ||
A common set of gene regulatory networks links metabolism and growth inhibition | Q28291530 | ||
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays | Q28646554 | ||
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 | Q29547773 | ||
Activators and target genes of Rel/NF-kappaB transcription factors | Q29547882 | ||
A global map of p53 transcription-factor binding sites in the human genome | Q29614400 | ||
Epidemiologic classification of human papillomavirus types associated with cervical cancer | Q29616213 | ||
siRNA-mediated gene silencing: a global genome view | Q30500906 | ||
NF-kappaB and not the MAPK signaling pathway regulates GADD45beta expression during acute inflammation | Q31157266 | ||
The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha | Q33292312 | ||
Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF. | Q33292449 | ||
The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. | Q33292571 | ||
Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. | Q33803580 | ||
Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes | Q33839638 | ||
Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis | Q34130066 | ||
Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16. | Q34347454 | ||
Biological activities and molecular targets of the human papillomavirus E7 oncoprotein | Q34468787 | ||
Molecular portraits and the family tree of cancer | Q35010198 | ||
The regulatory E2 proteins of human genital papillomaviruses are pro-apoptotic | Q35571503 | ||
Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract | Q35789790 | ||
Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix | Q37210134 | ||
Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. | Q37638673 | ||
The integration of HPV-18 DNA in cervical carcinoma | Q37642400 | ||
In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression | Q37685343 | ||
Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis | Q38299703 | ||
E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. | Q38304702 | ||
Pathway-specific profiling identifies the NF-kappa B-dependent tumor necrosis factor alpha-regulated genes in epidermal keratinocytes | Q38330398 | ||
Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system | Q38337784 | ||
Identification of target genes of the p16INK4A-pRB-E2F pathway. | Q38351396 | ||
Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. | Q38519339 | ||
The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes | Q39588185 | ||
Modulation of the cell division cycle by human papillomavirus type 18 E4. | Q39685193 | ||
Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. | Q39881041 | ||
p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis | Q40579357 | ||
Differential production of cytokines and activation of NF-kappaB in HPV-transformed keratinocytes | Q40717026 | ||
Transcriptional profiling of a human papillomavirus 33-positive squamous epithelial cell line which acquired a selective growth advantage after viral integration | Q40718613 | ||
The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex | Q40734787 | ||
The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. | Q40944954 | ||
Telomerase activation by the E6 gene product of human papillomavirus type 16. | Q41218028 | ||
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells | Q41914039 | ||
Species-specific regulation of Toll-like receptor 3 genes in men and mice. | Q42439173 | ||
Structure and expression of an integrated human papillomavirus type 16 genome amplified in a cervical carcinoma cell line | Q42641690 | ||
Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes. | Q42809799 | ||
Carcinogenicity of human papillomaviruses | Q58296516 | ||
Divergent gene regulation and growth effects by NF-κB in epithelial and mesenchymal cells of human skin | Q60726281 | ||
Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases? | Q69324793 | ||
Identification of HPV 16 early genes retained in cervical carcinomas | Q69839895 | ||
The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours | Q70093332 | ||
Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix | Q70094576 | ||
Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri | Q73721770 | ||
Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade | Q76383182 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 200-209 | |
P577 | publication date | 2006-06-30 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | Gene expression profiles reveal an upregulation of E2F and downregulation of interferon targets by HPV18 but no changes between keratinocytes with integrated or episomal viral genomes | |
P478 | volume | 353 |
Q40074658 | A novel splice donor site at nt 1534 is required for long-term maintenance of HPV31 genomes |
Q36245824 | Antagonist-mediated down-regulation of Toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus. |
Q37302893 | Cytotoxicity and DNA cleavage with core-shell nanocomposites functionalized by a KH domain DNA binding peptide. |
Q42707227 | Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein. |
Q38693402 | HPV16 E6 and E7 Upregulate Interferon-Induced Antiviral Response Genes ISG15 and IFIT1 in Human Trophoblast Cells |
Q28084802 | High-risk human papillomavirus targets crossroads in immune signaling |
Q38725533 | High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression |
Q36099378 | Integrative analyses reveal novel strategies in HPV11,-16 and -45 early infection |
Q41862182 | Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression. |
Q36434342 | Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins |
Q33574955 | MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients |
Q57064814 | Mechanisms of persistence by small DNA tumor viruses |
Q28742539 | Overexpression of Kpnβ1 and Kpnα2 importin proteins in cancer derives from deregulated E2F activity |
Q39816959 | RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells. |
Q41918717 | RNASeq analysis of differentiated keratinocytes reveals a massive response to late events during human papillomavirus type 16 infection, including loss of epithelial barrier function |
Q39393237 | Site-directed mutagenesis of human papillomavirus 18 promoter elements and tissue-specific expression in cervical carcinoma cells |
Q35274806 | Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility |
Q39501471 | The use of a human papillomavirus 18 promoter for tissue-specific expression in cervical carcinoma cells |
Q41713847 | Transcriptional regulation of genes involved in keratinocyte differentiation by human papillomavirus 16 oncoproteins. |
Search more.